ATARA BIOTHERAPEUTICS INC - PIERRE FABRE TO ASSUME COSTS FOR FDA REMEDIATION TO SUPPORT BLA RESUBMISSION FOR TAB-CEL - SEC FILING

Reuters · 04/04/2025 20:32

Please log in to view news